Scientific publications

Scientific Publication
16.09.2019

European Association for the Study of Diabetes (EASD) annual congress 2019 – TOTUM-63 corrects levels of hormones associated to type 2 diabetes.

View
Scientific Publication
07.06.2019

American Diabetes Association 2019 – 79th scientific sessions – TOTUM-63 lowers adipose tissue inflammation

View
Scientific Publication
12.11.2018

American Association for the Study of Liver Diseases (AASLD), 2018 Congress – TOTUM-63 reduces hepatic steatosis

View
Scientific Publication
04.10.2018

European Association for the Study of Diabetes (EASD), 2018 Congress, Berlin (Germany) – TOTUM-63 multi-target mode of action

View
Scientific Publication
07.03.2018

Keystone Symposia 2018, Banff (Canada) – LpD64 reduces intestinal dysbiosis associated with metabolic disorders

View
Scientific Publication
03.03.2018

Keystone Symposia 2018, Keystone (USA) – TOTUM-63 acts on intestinal microbiota

View
Scientific Publication
04.12.2017

International Diabetes Federation, 2017 Congress, Abu Dhabi (UAE) – TOTUM-63 reduces hepatic steatosis

View
Scientific Publication
06.06.2018

Cell Symposium 2017, San Diego (USA) – LpD64, in vivo effects on lipids metabolism

View
Scientific Publication
02.08.2017

American Diabetes Association, 2017 Congress, San Diego (USA) – VALEDIA®, results of the Phase I/II clinical study

View